MINTIE PRITCHARD: Open Payments
NPI 1396073656 · BECKLEY, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 36 payments from 14 companies in 2025. Trend: 2023 $1,424 · 2024 $1,376 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $228 |
| Novo Nordisk Inc | 5 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $31 |
| Abbott Laboratories | 1 | $24 |
| Corcept Therapeutics | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
Products named: VRAYLAR, QULIPTA, Ozempic, CAPLYTA, Auvelity, UBRELVY, MOUNJARO, FREESTYLE LIBRE 2.
Industry payments across WV — which companies pay providers there.
